“Dysregulated Circulating MiR-4429 Serves As a Novel Non-Invasive Biomarker and Is Correlated With EGFR Mutation in Patients With Non-Small Cell Lung Cancer”. 2022. Biomolecules and Biomedicine 22 (4): 553-59. https://doi.org/10.17305/bjbms.2021.6450.